Jan 7 2010
In a first-ever initiative, renowned health-care providers identify and
describe how cancer treatment-related toxicities have a negative effect
on quality of life from the perspective of patients and survivors. The
findings of this study, made possible by CancerCare and Lindi
Skin, are now available exclusively from the medical journal,
Supportive Care in Cancer, at http://www.springerlink.com/content/9n31658g173g1277/.
“Since
these events have a negative effect on survivors' lives, pretreatment
counseling and effective interventions are vital in order to maximize
quality of life and minimize unnecessary treatment interruptions or
discontinuations.”
“The impact of dermatologic toxicities was found to be unanticipated
prior to cancer treatments, to a greater degree than gastrointestinal
and constitutional side effects” stated Dr. Mario Lacouture, Associate
Attending Physician, Memorial Sloan-Kettering Cancer Center. “Since
these events have a negative effect on survivors' lives, pretreatment
counseling and effective interventions are vital in order to maximize
quality of life and minimize unnecessary treatment interruptions or
discontinuations.”
This landmark skincare study was pursued by medical leaders and centers
including: Mona Gandhi, Department of Dermatology, Northwestern
University’s Feinberg School of Medicine; Karen Oishi, University of
Texas, M.D. Anderson Cancer Center, Houston, TX; Beth Zubal, Washington
University School of Medicine, St. Louis, MO; and Dr, Mario E. Lacouture
SERIES Clinic, Robert H Lurie Comprehensive Cancer Center, Northwestern
University’s Feinberg School of Medicine, now at Memorial
Sloan-Kettering Cancer Center.
“Advances in cancer treatments have greatly improved survival rates for
many diagnoses. Yet, the lingering side effects of many cancer
treatments have only recently begun to be addressed,” said Rosalie
Canosa, Program Division Director, CancerCare. “This survey
breaks new ground in understanding not only the physical but also the
psychological impact of these side effects from the patient’s
perspective, and what can be done to help alleviate them.”
The results of this breakthrough study released by Supportive Care in
Cancer articulate that cancer survivors reported an increased
concern regarding dermatologic toxicities, including irritated and dry
skin, after receiving their cancer treatment. These events had a
negative effect on their lives.
http://www.springerlink.com/